AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

RecruitingNAAges 18 Years - 88 YearsAllPacific Edge Limited
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study includes adult patients who see a urologist because of blood in their urine. The amount is so small it can only be seen with a microscope. This is called microhematuria. There can be many reasons for microhematuria. One of them is bladder cancer. While bladder cancer is one of the biggest worries, it is only found in few of these patients. Most microhematuria patients will have a cystoscopy to look inside the bladder. During a cystoscopy, a small camera is inserted into the bladder. This is done through the urethra, the tube that passes urine from the bladder to the outside. In some patients it can cause pain or anxiety. Not all patients have a cystoscopy. Those that don't, usually return for a urine sample within 6 months. This is done to check if there is still blood in their urine. This study is conducted to find out if the use of "Cxbladder Triage Plus" changes the numbe

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Patient is referred for assessment of recent hematuria, defined as either: 1. Microscopic hematuria (โ‰ฅ3 RBC/HPF or equivalent) on urine microscopy obtained within 180 days prior to enrollment, OR 2. Hematuria detected by dipstick analysis (โ‰ฅ2+ blood or equivalent) at referral and confirmed on the same calendar day and prior to enrollment, with urine microscopy collected on the same day as enrollment 2. Physically able to provide a voided urine sample from a bladder that has not been surgically altered. 3. Able to give informed, written consent. 4. Able and willing to comply with study requirements. 5. Must be 19 or the legal age of consent in the jurisdiction in which the study is taking place to 88 years of age inclusive, at the time of signing the informed consent. 6. Ability to comprehend written and spoken English sufficiently to independently follow all study procedures. Or ability to comprehend Spanish with access to an English-Spanish interpreter for all study related verbal instructions and discussions. Exclusion Criteria: 1. Prior history of bladder malignancy. 2. Prior history of upper tract UC or prostatic urethral UC. 3. History of gross hematuria requiring instrumentation or hospitalization within the last 12 months 4. Reconstructed or diverted bladder (e.g., bladder augmentation, ileal conduit, Indiana pouch) 5. Indication to recommend cystoscopy other than MH (e.g., bothersome benign prostatic hyperplasia symptoms and desires a procedure, weak stream with concerns for urethral stricture). 6. Cystoscopy contraindicated due to another condition or anatomy. 7. History of pelvic radiation. 8. Currently receiving systemic chemotherapy or has had systemic chemotherapy within the last 6 weeks. 9. History of schistosomiasis. 10. History of chronic (\>3 months) indwelling Foley catheter or chronic (\>3 months) bladder stones. 11. Known current pregnancy
๐Ÿ’Š

What it tests

  • Cxbladder Triage Plus
๐Ÿ“

Where

20 sites
Urology Centers of Alabama
Homewood, United States
Urology Associates of Mobile
Mobile, United States
Urology Associates of Central California
Fresno, United States
Urology Group of Southern California
Los Angeles, United States
Comprehensive Urology
Los Angeles, United States
Advanced Urology Institute - Daytona Beach
Daytona Beach, United States
Urologic Specialists of Northwest Indiana
Merrillville, United States
Southern Urology
Lafayette, United States

โ€ฆand 12 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy